What Changed at VUNO

Every material change AI Health Index has tracked at VUNO: new modules, model and architecture updates, clinical evidence, regulatory status, security certifications, and integration depth. Each entry states what changed, cites its source, and carries our read on what it means for a buyer. The graded assessment of this vendor across all fifteen capability axes sits on its index profile.

Funding rounds, valuations, and awards are not product changes and are not logged here. Acquisitions appear only where there is direct product impact.

Impact
Type
1 entry
Showing changes for VUNO only.Show the full log

July 2026

V
VUNO
Jul 24, 2026
MediumVerified
Clinical evidence

Researchers from VUNO published a peer-reviewed study in the American Journal of Neuroradiology validating a machine learning algorithm that uses automated brain MRI volumetry to differentiate frontotemporal dementia from Alzheimer's disease. The model, trained on 758 subjects and externally validated on 89 subjects, achieved 91.4 percent accuracy internally and significantly reduced interpretation time for experienced radiologists.

Our read

Clinical leaders and radiology buyers evaluating dementia triage solutions gain peer-reviewed validation of VUNO's MRI volumetry approach. The demonstrated time savings and diagnostic accuracy support the commercial deployment of such models in clinical workflows to separate overlapping neurodegenerative presentations.

Related axis: Clinical and Operational EvidencePeer-reviewed publicationView source